Purpose: To study the effect of MARS on serum electrolytes during liver failure.
Design: Twenty-three patients admitted to a quaternary health care facility from September 2000 to May 2002, 22 adults and 1 child, 11 males (48%) and 12 females (52%), age 15-70 (median 53), treated with MARS for: 12 acute-on-chronic liver failure (52%); 4 fulminant hepatic failure (17%); 3 intractable pruritus (13%); 2 primary-non-function (9%); 2 following major liver resection (9%).
Procedures: Sodium, potassium, chloride, phosphorus, calcium, and magnesium were measured in the serum, ultrafiltrate and albumin circuit before and after MARS.
Statistical methods: A comparison of electrolyte concentrations, before and after MARS, was performed using a paired t test.
Main findings: Serum electrolyte concentrations before and after MARS, while statistically significant in some cases, were very small, and of no clinical relevance.
Conclusion: MARS exchanges potassium, chloride, calcium, and magnesium by ultrafiltration; sodium by the albumin dialysis.